Mira Pharmaceuticals reports oral formulation progress for MIRA-55
Go back to Mira Pharmaceuticals reports oral formulation progress for MIRA-55| Miracle Applications Corp (NASDAQ: MIRA) | Delayed: 0.87 +0.04 (4.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.83 | 52 Week High | $0.04 | |||
| Open | $0.82 | 52 Week Low | $0.00 | |||
| Day High | $0.90 | P/E | N/A | |||
| Day Low | $0.80 | EPS | $0.00 | |||
| Volume | 341,991 | |||||
